Prazosin Hydrochloride: FDA Recalls Blood Pressure Medication After Detecting Cancerous Substance

Blood pressure medication recall: More than half a million bottles of blood pressure medicine have been recalled due to the presence of a potential cancer-causing chemical, according to the U.S. Food and Drug Administration (FDA). Teva Pharmaceuticals USA, headquartered in Parsippany, New Jersey, issued a voluntary recall on October 7, 2025, for certain batches of prazosin hydrochloride capsules. The FDA later classified the situation as a Class II risk on October 24, 2025, which means that use or exposure could cause temporary or medically reversible health issues, though the chance of serious harm is considered low.Prazosin hydrochloride: FDA Recalls Blood Pressure MedicineTeva Pharmaceuticals announced the voluntary recall after the FDA identified a potential impurity in some batches of